New details have emerged about an initiative that starts in December to fast-track the vaccines, similar to the successful ...
BioNTech's cancer pipeline is bigger than its COVID-era reputation suggests, and the stock still trades below $100.
Phase Scientific founder Ricky Chiu is drawing on his firm's pandemic experience to advance early detection methods through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results